Richter's syndrome is a rare, aggressive transformation of CLL with few treatment options. Every gift supports Dr. Matthew Davids' research at Dana-Farber.




Dr. Matthew Davids and his team at Dana-Farber Cancer Institute are testing new approaches for patients whose CLL has transformed. Our gifts are unrestricted, so the team can move quickly on promising work.
Read Wendy's story →